Withania somnifera alleviates parkinsonian phenotypes by inhibiting apoptotic pathways in dopaminergic neurons. (Q54184805)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403619%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

Withania somnifera alleviates parkinsonian phenotypes by inhibiting apoptotic pathways in dopaminergic neurons (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403619%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

1 reference

Withania somnifera

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403619%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Jay Prakash

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403619%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Shikha Chouhan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403619%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Satyndra Kumar Yadav

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403619%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Susan Westfall

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403619%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Sachchida Nand Rai

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403619%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

18 November 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403619%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

published in

Neurochemical Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403619%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403619%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403619%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

2527-2536

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403619%20AND%20SRC:MED&resulttype=core&format=json

Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease

22 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

Withania somnifera root extract improves catecholamines and physiological abnormalities seen in a Parkinson's disease model mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

Paraquat induces oxidative stress, neuronal loss in substantia nigra region and parkinsonism in adult rats: neuroprotection and amelioration of symptoms by water-soluble formulation of coenzyme Q10

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

Resveratrol potentiates cytochrome P450 2 d22-mediated neuroprotection in maneb- and paraquat-induced parkinsonism in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

Exposure to pesticides or solvents and risk of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

Silymarin- and melatonin-mediated changes in the expression of selected genes in pesticides-induced Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

The novel tetramethylpyrazine bis-nitrone (TN-2) protects against MPTP/MPP+-induced neurotoxicity via inhibition of mitochondrial-dependent apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

Withania somnifera root extract prolongs analgesia and suppresses hyperalgesia in mice treated with morphine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

Axon- or dendrite-predominant outgrowth induced by constituents from Ashwagandha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

Sominone enhances neurite outgrowth and spatial memory mediated by the neurotrophic factor receptor, RET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

Effect of some Indian herbs on macrophage functions in ochratoxin A treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

The expression of CYP2D22, an ortholog of human CYP2D6, in mouse striatum and its modulation in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease phenotype and nicotine-mediated neuroprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

Analysis of withanolides in root and leaf of Withania somnifera by HPLC with photodiode array and evaporative light scattering detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

Effects of cypermethrin on monoamine transporters, xenobiotic metabolizing enzymes and lipid peroxidation in the rat nigrostriatal system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

Arginine vasopressin modulates expression of neuronal NOS in rat renal medulla

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

Involvement of nitric oxide in maneb- and paraquat-induced Parkinson's disease phenotype in mouse: is there any link with lipid peroxidation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

Assessment of symptomatic and neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

Comparison of the neuroprotective potential of Mucuna pruriens seed extract with estrogen in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mice model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

Cholinergic influence on memory stages: A study on scopolamine amnesic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

Selective killing of cancer cells by leaf extract of Ashwagandha: identification of a tumor-inhibitory factor and the first molecular insights to its effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

Environmental risk factors and Parkinson's disease: a case-control study in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

DNA fragmentation in human substantia nigra: apoptosis or perimortem effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

Relationships between indices of behavioral asymmetries and neurochemical changes following mesencephalic 6-hydroxydopamine injections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

Protective role of Ashwagandha leaf extract and its component withanone on scopolamine-induced changes in the brain and brain-derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

Products of oxidative stress inhibit aldehyde oxidation and reduction pathways in dopamine catabolism yielding elevated levels of a reactive intermediate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

Neurotoxicity and metabolism of the catecholamine-derived 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylglycolaldehyde: the role of aldehyde dehydrogenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

Evidence for intravenous dipyridamole (persantin) producing a "coronary steal" effect in the ischaemic myocardium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

Paraquat: model for oxidant-initiated toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

Astrocytes and Therapeutics for Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

Glial cells as players in parkinsonism: the "good," the "bad," and the "mysterious" glia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

Neuroglia in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

Recent advances in elucidating the biological properties of Withania somnifera and its potential role in health benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1443-7

Withania somnifera root extract in the regulation of lead-induced oxidative damage in male mouse.

21 January 2018

1 reference

12 December 2020

Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson's disease pathogenesis

1 reference

12 December 2020

Astrocytes differentially respond to inflammatory autoimmune insults and imbalances of neural activity

1 reference

12 December 2020

Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.

1 reference

12 December 2020

Neuroprotective role of Withania somnifera root extract in maneb-paraquat induced mouse model of parkinsonism

1 reference

12 December 2020

1 reference

12 December 2020

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2.

1 reference

12 December 2020

Free radical mediated cell toxicity by redox cycling chemicals

1 reference

12 December 2020

Parkinson disease in the elderly adult.

1 reference

12 December 2020

10.1007/S11064-014-1443-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403619%20AND%20SRC:MED&resulttype=core&format=json

release_biqlfsdscvdpzepcbz45ij4dvu

22 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/biqlfsdscvdpzepcbz45ij4dvu

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403619%20AND%20SRC:MED&resulttype=core&format=json